Immunosuppressive Drugs and the Risk of Cancer after Organ Transplantation

Improvements in immunosuppressive therapy during the past decade have brought us closer to the day when long-term acceptance of organ allografts will be routine. These achievements, however, have run up against an important limitation: death of the recipient from cardiovascular disease, infection, a... View More